AKBA logo

Akebia Therapeutics, Inc. (AKBA) Working capital

annual working capital:

$32.92M+$14.64M(+80.08%)
December 31, 2024

Summary

  • As of today (September 15, 2025), AKBA annual working capital is $32.92 million, with the most recent change of +$14.64 million (+80.08%) on December 31, 2024.
  • During the last 3 years, AKBA annual working capital has risen by +$22.82 million (+225.98%).
  • AKBA annual working capital is now -84.85% below its all-time high of $217.25 million, reached on December 31, 2017.

Performance

AKBA Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAbalance sheet metrics

quarterly working capital:

$115.94M+$3.38M(+3.01%)
June 1, 2025

Summary

  • As of today (September 15, 2025), AKBA quarterly working capital is $115.94 million, with the most recent change of +$3.38 million (+3.01%) on June 1, 2025.
  • Over the past year, AKBA quarterly working capital has increased by +$111.14 million (+2316.93%).
  • AKBA quarterly working capital is now -59.40% below its all-time high of $285.56 million, reached on March 31, 2018.

Performance

AKBA quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

AKBA Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+80.1%+2316.9%
3 y3 years+226.0%+64.5%
5 y5 years-67.5%-54.2%

AKBA Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-40.9%+226.0%at high+2316.9%
5 y5-year-82.1%+226.0%-54.2%+2316.9%
alltimeall time-84.8%+1328.5%-59.4%+4427.1%

AKBA Working capital History

DateAnnualQuarterly
Jun 2025
-
$115.94M(+3.0%)
Mar 2025
-
$112.56M(+241.9%)
Dec 2024
$32.92M(+80.1%)
$32.92M(-4.3%)
Sep 2024
-
$34.41M(+617.3%)
Jun 2024
-
$4.80M(-89.7%)
Mar 2024
-
$46.46M(+154.2%)
Dec 2023
$18.28M(-67.2%)
$18.28M(-38.9%)
Sep 2023
-
$29.90M(+13.8%)
Jun 2023
-
$26.26M(-30.5%)
Mar 2023
-
$37.77M(-32.1%)
Dec 2022
$55.65M(+451.1%)
$55.65M(+12.3%)
Sep 2022
-
$49.55M(-29.7%)
Jun 2022
-
$70.48M(+44.5%)
Mar 2022
-
$48.77M(+383.0%)
Dec 2021
$10.10M(-94.5%)
$10.10M(-92.8%)
Sep 2021
-
$140.88M(-14.9%)
Jun 2021
-
$165.48M(-14.0%)
Mar 2021
-
$192.34M(+4.4%)
Dec 2020
$184.29M(+81.7%)
$184.29M(-12.1%)
Sep 2020
-
$209.54M(-17.3%)
Jun 2020
-
$253.33M(+100.1%)
Mar 2020
-
$126.60M(+24.8%)
Dec 2019
$101.42M
$101.42M(+33.7%)
Sep 2019
-
$75.86M(-42.0%)
Jun 2019
-
$130.78M(-9.6%)
DateAnnualQuarterly
Mar 2019
-
$144.62M(-28.6%)
Dec 2018
$202.58M(-6.8%)
$202.58M(-8.0%)
Sep 2018
-
$220.13M(-9.4%)
Jun 2018
-
$243.00M(-14.9%)
Mar 2018
-
$285.56M(+31.4%)
Dec 2017
$217.25M(+19.3%)
$217.25M(+19.0%)
Sep 2017
-
$182.58M(+21.1%)
Jun 2017
-
$150.80M(+24.0%)
Mar 2017
-
$121.59M(-33.2%)
Dec 2016
$182.05M(+41.0%)
$182.05M(+31.0%)
Sep 2016
-
$139.01M(-19.0%)
Jun 2016
-
$171.59M(-16.8%)
Mar 2016
-
$206.12M(+59.6%)
Dec 2015
$129.15M(+24.7%)
$129.15M(-10.7%)
Sep 2015
-
$144.64M(-3.0%)
Jun 2015
-
$149.06M(+58.8%)
Mar 2015
-
$93.85M(-9.4%)
Dec 2014
$103.59M(+250.8%)
$103.59M(-8.6%)
Sep 2014
-
$113.32M(-6.6%)
Jun 2014
-
$121.28M(-5.0%)
Mar 2014
-
$127.62M(+332.2%)
Dec 2013
$29.53M(-1202.1%)
$29.53M(-1202.1%)
Dec 2012
-$2.68M(-149.7%)
-
Dec 2012
-
-$2.68M
Dec 2011
$5.39M
-

FAQ

  • What is Akebia Therapeutics, Inc. annual working capital?
  • What is the all time high annual working capital for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. annual working capital year-on-year change?
  • What is Akebia Therapeutics, Inc. quarterly working capital?
  • What is the all time high quarterly working capital for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. quarterly working capital year-on-year change?

What is Akebia Therapeutics, Inc. annual working capital?

The current annual working capital of AKBA is $32.92M

What is the all time high annual working capital for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high annual working capital is $217.25M

What is Akebia Therapeutics, Inc. annual working capital year-on-year change?

Over the past year, AKBA annual working capital has changed by +$14.64M (+80.08%)

What is Akebia Therapeutics, Inc. quarterly working capital?

The current quarterly working capital of AKBA is $115.94M

What is the all time high quarterly working capital for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high quarterly working capital is $285.56M

What is Akebia Therapeutics, Inc. quarterly working capital year-on-year change?

Over the past year, AKBA quarterly working capital has changed by +$111.14M (+2316.93%)
On this page